Aristotle University of Thessaloniki School of Medicine;
1st Department of Surgery;
Aristotle University of Thessaloniki;
Sorafenib; Hepatocellular; carcinoma; Liver; neoplasm; Multikinase; inhibitor; Targeted; therapy; Tumor; angiogenesis; Signaling; pathways; Adjuvant; therapy; Liver; cancer; Liver; transplantation; Liver; resection;